Related Experiment Video
Updated: Apr 18, 2026
08:36
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
13.0K
[Vasopressin and jet lag disordes]
Pediatric Endocrinology, Diabetes, and Metabolism
|January 24, 2015
Summary
Altering vasopressin V1a and V1b receptors in the suprachiasmatic nucleus (SCN) can prevent circadian rhythm disruptions like jet lag disorder (JLD). This research offers hope for travelers and shift workers facing rhythm-related health issues.
Area of Science:
- Neuroscience
- Chronobiology
- Physiology
Background:
- Circadian rhythms are crucial for human physiology, and their disruption causes jet lag disorder (JLD) and metabolic issues in shift workers.
- The suprachiasmatic nucleus (SCN) in the hypothalamus, particularly vasopressin V1a and V1b receptors, is implicated in circadian rhythm regulation.
Purpose of the Study:
- To investigate the role of vasopressin V1a and V1b receptors in the SCN for circadian rhythm regulation.
- To explore potential therapeutic strategies for jet lag disorder and shift work adaptation.
Main Methods:
- Studied genetically modified mice lacking vasopressin V1a and V1b receptors.
- Examined the effects of pharmacologically blocking these receptors on circadian rhythm adjustment.
Main Results:
- Mice lacking vasopressin V1a and V1b receptors demonstrated resistance to circadian rhythm disturbances.
- These mice exhibited rapid adjustment to new environmental rhythms.
- Pharmacological blockade of V1a and V1b receptors mimicked this effect.
Conclusions:
- Vasopressin V1a and V1b receptors in the SCN are key regulators of circadian rhythm.
- Targeting these receptors offers a promising therapeutic avenue for managing jet lag disorder and facilitating adaptation to shift work without adverse health consequences.
Related Concept Videos
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
488
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
488
01:24Sleep-Wake Cycles
3.5K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.5K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
944
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
944
01:29Diabetes Insipidus I: Introduction
6
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
6
01:22Diabetes Insipidus II: Pathophysiology
7
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
7
01:24Substance Use Disorders Affecting Sleep
580
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
580